Skip to main content
Back to feed
MarketsSingle-sourceLowDeveloping
2.0

Oncolytics Biotech Inc. Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price

Oncolytics Biotech Inc. has disclosed receipt of a notification from Nasdaq indicating non-compliance with the minimum $1.00 bid price requirement for continued listing. The company has 180 days to regain compliance, though the outcome remains uncertain and depends on future share price performance.

SEC EDGAR 8-K Filingsabout 7 hours agoUS, CACredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

#nasdaq#delisting#biotech#compliance#equity

Locations

Nasdaq Stock Market

Entities

countrycountry
Source

Related signals

8 found